Literature DB >> 8823596

Effects and side effects of mydriatic eyedrops in neonates.

M S Oğüt1, N Bozkurt, E Ozek, H Birgen, H Kazokoğlú, M Oğüt.   

Abstract

The pupils of neonates and premature infants often need to be dilated for retinal examination. The drops used for this purpose have some known side effects. This study investigated the effects and side effects of these drops. In this prospective randomized study, 80 healthy neonates were randomly assigned to eight groups. In Group A 1% cyclopentolate was used; in Group B 1% tropicamide; in Group C 2.5% phenylephrine; in Group D 1% cyclopentolate and 1% tropicamide; in Group E 2.5% phenylephrine and 1% tropicamide; in Group F 0.5% cyclopentolate, 0.5% tropicamide and 2.5% phenylephrine; in Group G 1% cyclopentolate and 2.5% phenylephrine and in Group H 0.9% NaCl. Heart rate, systolic and diastolic blood pressures were recorded before, and 5, 10, 15, 30, 45, 60 minutes after instillation of the drops. Pupillary size was measured at baseline, 30 and 60 minutes. To stimulate the conditions of indirect ophthalmoscopic examination, the pupil sizes were measured under the intense beam of a halogen light. The results were analyzed statistically. Maximum side effects were seen in group C; the safest was group B and maximum mydriasis was achieved in group F.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823596     DOI: 10.1177/112067219600600218

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  10 in total

1.  The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Authors:  Atilla Alpay; Bahri Ermis; Silay C Ugurbas; Fatih Battal; Haci Murat Sagdik
Journal:  Eur J Clin Pharmacol       Date:  2010-09-11       Impact factor: 2.953

2.  [Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].

Authors:  K Heimann; T Peschgens; U Merz; H Hoernchen; T Wenzl
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

Review 3.  The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery.

Authors:  Lola Elizabeth Lawuyi; Avinash Gurbaxani
Journal:  Clin Ophthalmol       Date:  2015-07-10

Review 4.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

5.  Pupil dilation with intra-cameral lidocaine versus topical midriatics during phacoemulsification.

Authors:  Vafa Samarai; Negar Haghighi; N Sharifi
Journal:  Glob J Health Sci       Date:  2014-09-18

6.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09

7.  Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.

Authors:  Atilla Alpay; Sılay Canturk Ugurbas; Cumhur Aydemir
Journal:  BMC Pediatr       Date:  2019-11-06       Impact factor: 2.125

8.  Direct and crossover effects of Phenylephrine and Cyclopentolate on foveal avascular zone and vessel density of macular capillary plexuses: an optical coherence tomography angiography study.

Authors:  Yasin Şakir Göker; Hasan Kızıltoprak; Kemal Tekin; Esat Yetkin; Mustafa Salih Karatepe; Kübra Özdemir; Gokhan Demir
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

9.  Pupil dilation with intracameral lidocaine during phacoemulsification: Benefits for the patient and surgeon.

Authors:  Aminollah Nikeghbali; Khalil Ghasemi Falavarjani; Ahmad Kheirkhah
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

10.  Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.

Authors:  Tohid Seif Barghi; Farzad Kobarfard; Ahmad Hashemian; Jayran Zebardast
Journal:  Asian J Sports Med       Date:  2015-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.